Self-Monitoring Blood Glucose Devices Market Is Likely To Expand At an Estimated CAGR Of 4.2% from 2018 – 2025: Allied Market Research

Rise in prevalence of diabetes, increase in obese and geriatric population, sedentary lifestyle, technological advancements in diabetes devices and increased need for faster, safer diagnosis and treatment of diabetes drive the growth of the global self-monitoring blood glucose devices market.

However, the inability of blood glucose monitoring devices to measure the exact level of glucose and adverse effects associated with some of the diabetes care devices hinder market growth. Conversely, the rise in awareness about diabetes monitoring devices as well as high potential in untapped markets in emerging economies are expected to provide lucrative growth opportunities for market growth.

Request Sample Available @ https://www.alliedmarketresearch.com/request-sample/4149

The report offers insights on major market segments, top investment pockets, key player positioning, drivers & opportunities, and strategic developments in the industry. According to the report, the global self-monitoring blood glucose devices market garnered $7.76 billion in 2017 and is projected to reach $10.82 billion through 2025, growing at a CAGR of 4.2% from 2018 to 2025.

Major Players:

• Abbott Laboratories
• Becton
• Dickinson and Company
• B. Braun Melsungen AG
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
• Medtronic plc
• PHC Holdings Corporation
• Sanofi S.A.

North America to be dominant, Asia-Pacific to grow the fastest

North America accounted for 40% of the total market share in 2017 and would maintain its lead position through 2025. This is attributed to factors such as new product launches, increased adoption of advanced glucose meters, and large obese population in the region.

However, Asia-Pacific would grow at the fastest CAGR of 5.5% during the forecast period owing to the rapidly changing healthcare infrastructure in developing counties such as India and China, growth of medical tourism industry, rise in number of diabetes cases, increase in awareness of diabetes management, and boost in per capita income. The other regions analyzed in the report include Europe and Latin America, Middle East & Africa (LAMEA).

Report Enquiry Available @ https://www.alliedmarketresearch.com/purchase-enquiry/4149

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.